Analystreport

Wave Life Sciences Ltd (NASDAQ: WVE) had its price target raised by analysts at Leerink Swann from $53.00 to $64.00. They now have an "outperform" rating on the stock.

Wave Life Sciences Ltd. - Ordinary Shares  (WVE) 
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am Check Earnings Report